Business / Finance

RSS

Seeing the unseen, together. 3DHISTECH and Barco at the 20th European Congress on Digital Pathology 2024

The ECDP 2024 event brings together experts, researchers, and industry leaders in the field of digital pathology. Join us from June 6th to June 8th in Vilnius, Lithuania, for an exciting collaboration that promises to advance research and innovation!

From 3DHISTECH 23 Sep 2024

MaxCyte signs strategic platform license with Kamau Therapeutics to accelerate the development of cell therapies for genetic diseases

MaxCyte, Inc., a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and innovative bioprocessing applications, and Kamau Therapeutics, a clinical-stage stem cell therapy gene correction company, today announced they are entering into a strategic platform license (SPL) agreement.

From MaxCyte, Inc. 23 Sep 2024

analytica expands its international network to the USA

analytica is expanding its international network and will launch analytica USA in Columbus, Ohio, in fall 2025, to cover the North American market. The new offshoot of the world's leading trade fair for laboratory technology, analysis and biotechnology will take place at the Greater Columbus Convention Center from September 10 to 12.

20 Sep 2024

Lonza nominates Juan Andres and Eric Drapé as independent Board Members

Today, the Lonza Board of Directors announced the nomination of Juan Andres and Eric Drapé as Independent Members of the Board. The Board will propose to shareholders the election of both nominees at the Lonza Group Annual General Meeting (AGM) in May 2025.

From Lonza 20 Sep 2024

Asimov launches AAV Edge, a suite of AI models, host cells, and genetic tools for end-to-end gene therapy development

Asimov, the synthetic biology company advancing the design and production of therapeutics, today announced the launch of the AAV Edge System, a comprehensive suite of tools for adeno-associated viral (AAV) gene therapy design and manufacturing.

18 Sep 2024

LabVantage named Global LIMS Company of the year by Frost & Sullivan

LabVantage Solutions, Inc., the leading provider of laboratory informatics solutions and services, including purpose-built LIMS platforms enabling rapid deployment at reduced costs, today announced it has been awarded the prestigious Company of the Year Award in the Global Laboratory Information Management Systems (LIMS) Industry by Frost & Sullivan.

From LabVantage Solutions 17 Sep 2024

MicrosensDx collaborates with Imperial researchers to develop groundbreaking sepsis test

MicrosensDx is excited to announce that it is working with The Mayr Group at Imperial College London to develop a novel biomarker test for the early recognition of sepsis.

From MicrosensDx 17 Sep 2024

Flow Robotics and Global Focus announce distribution partnership in USA

Flow Robotics, Copenhagen, Denmark and Global Focus, Dallas, Texas, will bring the liquid handler, flowbot® ONE, and other products to labs throughout USA.

From Flow Robotics 14 Sep 2024

Winner in the product: Medicine/health category

Automata is pleased to announce that LINQ has won an iF DESIGN AWARD in the category of Product: Medicine/Health (1.22).

From Automata 6 Sep 2024

Akebia Therapeutics to present at upcoming investor conferences

Akebia Therapeutics®, Inc., a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that its executives will participate in two investor conferences in September: Wells Fargo Healthcare Conference on September 4-6, 2024 in Boston and H.C. Wainwright 26th Annual Global Investment Conference on September 9-11, 2024 in New York.

From Akebia Therapeutics 4 Sep 2024

Logical Biological appoints Stephane Argivier as new CEO

Logical Biological, a leader in the provision of high-quality biological specimens, announces the appointment of Stephane Argivier as its new Chief Executive Officer, effective from 1st September 2024. Stephane Argivier will lead the next stage in the company’s expansion and succeeds Dr. James Steggles, the company’s founder, who announces he will remain Chair of the Board.

From Logical Biological 4 Sep 2024

Sapio Sciences advances the world's first AI-powered lab assistant

Sapio ELaiN couples AI and natural language processing to deliver the future interface for scientists and lab operations.

From Sapio Sciences 3 Sep 2024

Aptamer extends contract with Unilever to progress Optimer for deodorant development

Lab-test results of Optimer indicate good applicability in deodorant products.

From Aptamer Group 3 Sep 2024

Micropore appoints Insung Chroma-Tech Co as korean distributor

Micropore Technologies has just announced the appointment of Insung Chroma-Tech Co. as the distributor for its patented membrane technology in the Korean market

From Micropore Techologies 30 Aug 2024

Micropore appoints new CEO

Kay joins the business at a significant turning point for the company. Micropore is transitioning from an early-stage proof of concept into a fully developed drug delivery solution.

From Micropore Techologies 30 Aug 2024

Juan Pablo Ramírez Torrealba is a new General Manager in chile

Benchmark Genetics Chile is pleased to announce that Juan Pablo Ramírez Torrealba will assume the role of General Manager, succeeding Berta Contreras Mutis, who will be pursuing new professional opportunities.

From Benchmark Genetics 30 Aug 2024

SciY and Allchemy announce strategic distribution agreement

SciY is proud to announce a strategic distribution agreement with Allchemy, a pioneer in Artificial Intelligence (AI) driven drug discovery, co-founded by renowned experts Dr. Sara Szymkuć and Prof. Bartosz Grzybowski.

From SciY 28 Aug 2024

Introducing Chemspeed’s new corporate design

We are thrilled to announce the launch of Chemspeed’s new Corporate Design! This update marks a significant milestone in our journey to modernize and strengthen our brand identity, ensuring it reflects our innovative spirit and commitment to excellence.

From Chemspeed 27 Aug 2024

ATS completes acquisition of Avidity Science

ATS Corporation (“ATS”), today announced the successful completion of its acquisition of Avidity Science, LLC ("Avidity"), a growing designer and manufacturer of automated water purification solutions for biomedical and life science applications.

From Avidity Science 27 Aug 2024

Ingenza announces partnership with Cellugy to investigate the potential of biofabricated cellulose

Industrial biotech specialist Ingenza is delighted to announce that it is collaborating with Cellugy to accelerate the development of its innovative platform for producing biofabricated cellulose.

From Ingenza Ltd 23 Aug 2024